Health Care: Drugs

Actavis PLC (ACT: NYSE)

$226.98 0.39 | 0.17%
08/29/14 - 04:04 PM ET
TheStreet Ratings Grade for ACT
BuyHoldSell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F

TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.

Click here to find out about our methodology.

Analyst Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 15 15 15 14
Moderate Buy 1 1 1 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.03 1.03 1.03 1.00

Portfolios with ACT

Latest ACT Headlines from TheStreet

More Financial News for ACT

Press Releases for ACT

See All Press Releases

Partner Headlines for ACT

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter